Inventor · disambiguated record
Rodolfo Testa
Also filed as: TESTA RODOLFO
18 granted patents·7 pending applications·455 citations·filing 1982–2006
95Inventor score
Top patents by PatentIndex Score
25 records- 0196US5605896ABicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activitiesRECORDATI CHEM PHARM·Filed 1994·Granted Feb 25, 1997·87 cites·24 claims
- 0295US7071197B2N,N-disubstituted diazocycloalkanesRECORDATI CHEM PHARM·Filed 2003·Granted Jul 4, 2006·49 cites·4 claims
- 0392US5474994ABicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1ARECORDATI CHEM PHARM·Filed 1993·Granted Dec 12, 1995·52 cites·16 claims
- 0491US5403842ABenzopyran and benzothiopyran derivativesRECORDATI CHEM PHARM·Filed 1992·Granted Apr 4, 1995·49 cites·29 claims
- 0587US6306861B1Thienopyrancecarboxamide derivativesRECORDATI CHEM PHARM·Filed 2000·Granted Oct 23, 2001·15 cites·23 claims
- 0685US6303606B1Use of selective antagonists of the α1B-adrenergic receptor for improvement of sexual dysfunctionRECORDATI CHEM PHARM·Filed 2000·Granted Oct 16, 2001·22 cites·46 claims
- 0784US6440963B1Use of selective COX-2 inhibitors for the treatment of urinary incontinenceRECORDATI CHEM PHARM·Filed 2001·Granted Aug 27, 2002·26 cites·83 claims
- 0884US6399614B11-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ringRECORDATI CHEM PHARM·Filed 2000·Granted Jun 4, 2002·14 cites·62 claims
- 0982US6486163B1Thienopyranecarboxamide derivativesRECORDATI CHEM PHARM·Filed 2001·Granted Nov 26, 2002·9 cites·14 claims
- 1078US6387909B1Thienopyranecarboxamide derivativesRECORDATI CHEM PHARM·Filed 2000·Granted May 14, 2002·8 cites·18 claims
- 1171US5767136A1,4-Dihydropyridines useful for prevention or reduction of atherosclerotic lesions on arterial wallsRECORDATI CHEM PHARM·Filed 1996·Granted Jun 16, 1998·38 cites·25 claims
- 1269US6071920A1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ringRECORDATI CHEM PHARM·Filed 1998·Granted Jun 6, 2000·26 cites·21 claims
- 1363US5696139AUse of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failureRECORDATI CHEM PHARM·Filed 1996·Granted Dec 9, 1997·25 cites·9 claims
- 1461US5990114AUse of 5-HT1A receptor antagonists for the treatment of urinary incontinenceRECORDATI CHEM PHARM·Filed 1997·Granted Nov 23, 1999·23 cites·35 claims
- 1553US2004215284A1Treatment of neuromuscular dysfunction of the lower urinary tract with selective mGlu5 antagonistsRECORDATI CHEM PHARM·Filed 2004·Application pending·0 cites
- 1649US2002183290A1Adrenergic receptor antagonists selective for both alpha1A-and alpha1D-subtypes and uses thereforRECORDATI CHEM PHARM·Filed 2002·Application pending·0 cites
- 1748US2003162777A1Novel N-acylated heterocyclesRECORDATI CHEM PHARM·Filed 2002·Application pending·0 cites
- 1848US2003181446A1Novel N-acylated heterocyclesRECORDATI CHEM PHARM·Filed 2002·Application pending·0 cites
- 1948US2005165025A1Combination therapy with 5HT 1A and 5HT 1B-receptor antagonistsRECORDATI IRELAND LTD·Filed 2005·Application pending·0 cites
- 2047US5798362AQuinazolinyl-amino derivatives having α-antagonist activityRECORDATI CHEM PHARM·Filed 1995·Granted Aug 25, 1998·9 cites·30 claims
- 2144US2006148821A1N,N-disubstituted diazocycloalkanesRECORDATI CHEM PHARM·Filed 2006·Application pending·0 cites
- 2241US2002193383A11-(N-phenylalkylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ringRECORDATI CHEM PHARM·Filed 2002·Application pending·0 cites
- 2337US4507308AAnalgesically or anti-inflammatory effective 4-quinolyl anthranilic acid derivativesRECORDATI CHEM PHARM·Filed 1982·Granted Mar 26, 1985·1 cites·10 claims
- 2435US6894052B1Diarylalkylpiperazines active on the lower urinary tractRECORDATI CHEM PHARM·Filed 1998·Granted May 17, 2005·1 cites·8 claims
- 2535US4482561ATherapeutically effective piperidyl N-(4-quinolyl)-anthraniloyloxyalkanoatesRECORDATI CHEM PHARM·Filed 1982·Granted Nov 13, 1984·1 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Rodolfo Testa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →